208 related articles for article (PubMed ID: 38001474)
1. Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial.
Werida RH; Ramzy A; Ebrahim YN; Helmy MW
BMC Endocr Disord; 2023 Nov; 23(1):259. PubMed ID: 38001474
[TBL] [Abstract][Full Text] [Related]
2. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H
BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527
[TBL] [Abstract][Full Text] [Related]
4. The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial.
Bazyar H; Moradi L; Zaman F; Zare Javid A
Phytother Res; 2023 Jan; 37(1):271-284. PubMed ID: 36101997
[TBL] [Abstract][Full Text] [Related]
5. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.
Wang F; Wang Y; Zhu Y; Liu X; Xia H; Yang X; Sun G
Eur J Nutr; 2017 Oct; 56(7):2415-2422. PubMed ID: 27913872
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
Aghasi M; Koohdani F; Qorbani M; Nasli-Esfahani E; Ghazi-Zahedi S; Khoshamal H; Keshavarz A; Sotoudeh G
J Sci Food Agric; 2019 Jun; 99(8):3933-3940. PubMed ID: 30701554
[TBL] [Abstract][Full Text] [Related]
9. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
[TBL] [Abstract][Full Text] [Related]
11. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
[TBL] [Abstract][Full Text] [Related]
12. Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.
Jacobo-Cejudo MG; Valdés-Ramos R; Guadarrama-López AL; Pardo-Morales RV; Martínez-Carrillo BE; Harbige LS
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587203
[TBL] [Abstract][Full Text] [Related]
13. Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial.
Zheng JS; Lin M; Fang L; Yu Y; Yuan L; Jin Y; Feng J; Wang L; Yang H; Chen W; Li D; Tang J; Cai W; Shi M; Li Z; Wang F; Li D
Mol Nutr Food Res; 2016 Oct; 60(10):2176-2184. PubMed ID: 27279274
[TBL] [Abstract][Full Text] [Related]
14. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
15. The effect of a low renal acid load diet on blood pressure, lipid profile, and blood glucose indices in patients with type 2 diabetes: a randomized clinical trial.
Armin M; Heidari Z; Askari G; Iraj B; Clark CCT; Rouhani MH
Nutr J; 2023 Mar; 22(1):18. PubMed ID: 36918899
[TBL] [Abstract][Full Text] [Related]
16. Effects of marine-derived and plant-derived omega-3 polyunsaturated fatty acids on erythrocyte fatty acid composition in type 2 diabetic patients.
Liu H; Wang F; Liu X; Xie Y; Xia H; Wang S; Sun G
Lipids Health Dis; 2022 Feb; 21(1):20. PubMed ID: 35144649
[TBL] [Abstract][Full Text] [Related]
17. The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes.
Jamilian M; Samimi M; Ebrahimi FA; Hashemi T; Taghizadeh M; Razavi M; Sanami M; Asemi Z
J Clin Lipidol; 2017; 11(2):459-468. PubMed ID: 28502503
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial.
Elbarbary NS; Ismail EAR; Mohamed SA
Clin Nutr; 2023 Dec; 42(12):2372-2380. PubMed ID: 37862823
[TBL] [Abstract][Full Text] [Related]
19. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
Roberts VL; Stewart J; Issa M; Lake B; Melis R
Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
[TBL] [Abstract][Full Text] [Related]
20. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
